Natco Pharma share price hits 52- week high on DCGI nod for production of #39;Black Fungus#39; drug Dayanand Saini | May 25, 2021 | Stocks News | No Comments DCGI approved application of five companies incuding Natco Pharma to begin production of antifungal drug Amphotericin B liposomal injection, which is critical in the treatment of Mucormycosis, also called #39;Black Fungus#39;. Related Posts #39;Bet on these 9 stocks for 17-34% return as Nifty is set to scale 21,000 points in 2022#39; No Comments | Dec 29, 2021 Buzzing Stocks: Tata Motors, Axis Bank, Sun Pharma and others that will be in focus today No Comments | May 19, 2021 Zee Entertainment shares dip 4% after Delhi HC dismisses company appeal No Comments | Dec 23, 2020 Gainers Losers: 10 stocks that moved the most on November 20 No Comments | Nov 21, 2020 About The Author Dayanand Saini